A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor

Recombinant human arginase (rhArg), an enzyme capable of depleting arginine, has been shown to be an effective therapeutic approach for various cancers. Non-small-cell lung cancer (NSCLC), a histological subtype of pulmonary carcinoma, has a high rate of morbidity and mortality in the world. Thus, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Weitao, Zhang, Xuyao, Fu, Xiang, Fan, Jiajun, Luan, Jingyun, Cao, Zhonglian, Yang, Ping, Xu, Zhongyuan, Ju, Dianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386540/
https://www.ncbi.nlm.nih.gov/pubmed/28358368
http://dx.doi.org/10.1038/cddis.2017.137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386540/
https://www.ncbi.nlm.nih.gov/pubmed/28358368
http://dx.doi.org/10.1038/cddis.2017.137

Ejemplares similares